Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma [Phase 1]

View source ↗

Summary

This entry summarizes the completion of a Phase 1 study evaluating the safety, pharmacokinetics, and anti-tumor activity of RO7428731 in patients with glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• RO7428731 (RO7428731)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED